Introduction
Cameron lesions are a specific type of mucosal erosion located on the proximal esophagus, typically at the gastroesophageal junction where a hiatal hernia is present. First described in the early 1990s, these lesions have gained recognition as a distinct pathological entity associated with iron‑deficiency anemia in patients who otherwise exhibit no obvious source of chronic blood loss. The lesions are named after the gastroenterologist who first characterized them in a series of case reports. Although uncommon, Cameron lesions have a clinically significant impact because they can be a hidden cause of anemia, especially in patients with large type I hiatal hernias. This article provides a comprehensive overview of Cameron lesions, covering their definition, epidemiology, pathophysiology, clinical presentation, diagnostic approach, management, and current research directions.
Definition and Terminology
Histological Features
Histologically, Cameron lesions appear as shallow, irregular erosions of the superficial epithelium of the esophageal mucosa. The underlying lamina propria may show focal inflammatory infiltrates, predominantly neutrophils and occasional lymphocytes, and there may be evidence of microvascular congestion. In some cases, the erosions may contain small fibrin‑rich clots that suggest active bleeding. Importantly, the lesions are not ulcerative in the classic sense; they are typically limited to the mucosal layer and do not penetrate deeper into the submucosa or muscularis propria.
Clinical Terminology
Because the lesions are usually discovered incidentally during endoscopy performed for other indications, the term “Cameron lesion” is most commonly used in the context of endoscopic findings. They are often described as “diaphragmatic mucosal erosions” or “hiatal erosions.” When they are associated with significant bleeding, the terminology shifts to “esophageal erosion” or “diaphragmatic erosion,” but the underlying pathology remains the same.
Epidemiology and Demographics
Prevalence
Studies that have systematically examined esophagogastroduodenoscopy (EGD) findings in patients with hiatal hernia have reported an incidence of Cameron lesions ranging from 1 % to 9 %. The variation depends largely on the size of the hernia, the presence of reflux esophagitis, and the patient population studied. Patients with large, type I hiatal hernias - those in which the stomach protrudes into the thoracic cavity - are most frequently affected.
Age and Sex Distribution
Cameron lesions are most often diagnosed in adults aged 50 to 80 years, with a slight predominance in males. However, because the lesions are frequently discovered incidentally, many reports have not been systematic enough to ascertain true gender differences. In pediatric patients, the lesions are rare, and there is a paucity of data regarding their occurrence in younger age groups.
Risk Factors
- Large type I hiatal hernia
- Severe gastroesophageal reflux disease (GERD)
- Use of nonsteroidal anti‑inflammatory drugs (NSAIDs) or aspirin
- Concurrent iron‑deficiency anemia
- Smoking and alcohol consumption (though the evidence is mixed)
Pathophysiology
Mechanical Stress at the Diaphragmatic Hiatus
In patients with a large hiatal hernia, the stomach moves back and forth within the thoracic cavity during respiration and peristalsis. This repetitive motion subjects the diaphragmatic mucosa to shear forces and friction against the esophageal wall. The mucosal damage is exacerbated by the presence of gastric acid, which can erode the vulnerable epithelium.
Acid Exposure and Reflux
Reflux of gastric contents into the proximal esophagus is a hallmark of GERD and contributes to mucosal injury. Histological examination of Cameron lesions often shows focal acid‑induced erosion, with evidence of epithelial desquamation and microerosions. In addition, bile salts can further damage the mucosa by disrupting epithelial integrity and promoting inflammation.
Inflammatory Response
The mechanical and chemical insults trigger an inflammatory cascade that involves neutrophil recruitment, cytokine release (e.g., interleukin‑1β, tumor necrosis factor‑α), and activation of proteolytic enzymes. These inflammatory mediators can increase vascular permeability, leading to edema and microhemorrhages. The combination of mechanical trauma and inflammation results in the characteristic shallow erosions that define Cameron lesions.
Hemodynamic Factors
During inspiration, intrathoracic pressure decreases, which can draw the gastric content upward and increase pressure at the hiatus. Conversely, during expiration, intrathoracic pressure rises, potentially compressing the gastric fundus against the esophageal wall. This dynamic pressure cycle may further contribute to mucosal injury and the formation of erosions.
Clinical Presentation
Symptomatology
Many patients with Cameron lesions are asymptomatic, and the lesions are discovered incidentally during EGD for unrelated reasons. When symptoms are present, they are usually nonspecific and may include heartburn, regurgitation, dysphagia, or epigastric discomfort. Classic presentation associated with the lesions is iron‑deficiency anemia, often discovered during routine laboratory workup.
Iron‑Deficiency Anemia
Iron‑deficiency anemia is the most frequent systemic manifestation of Cameron lesions. The anemia is typically microcytic and hypochromic, and it may be accompanied by low ferritin and elevated total iron‑binding capacity. The anemia can be mild to moderate, but in some cases, it can become severe enough to cause fatigue, pallor, and dyspnea on exertion.
Hemorrhage
Although rare, Cameron lesions can bleed actively, leading to melena or hematochezia. The bleeding episodes are usually self‑limited and may resolve spontaneously. In severe cases, endoscopic intervention or surgery may be required.
Other Clinical Findings
- Recurrent episodes of reflux esophagitis
- Gastric outlet obstruction in massive hernias
- Esophageal strictures secondary to healing erosions
Diagnosis
Endoscopic Evaluation
EGD is the gold standard for detecting Cameron lesions. During the procedure, the gastroenterologist examines the proximal esophagus and the gastroesophageal junction, looking for shallow, irregular erosions along the diaphragmatic margin. The lesions may appear reddish or pale and are often situated at the base of the hiatal hernia. In some cases, a magnifying endoscope with narrow‑band imaging can enhance visualization of microvascular changes and mucosal detail.
Biopsy
When lesions are suspected, a biopsy can confirm the diagnosis. Histopathology typically reveals superficial mucosal erosion with neutrophilic infiltrate and no evidence of malignancy. Care must be taken to avoid inducing significant bleeding during biopsy, especially in patients with active anemia.
Laboratory Tests
- Complete blood count (CBC) to assess for microcytic anemia
- Serum ferritin and iron studies to confirm iron deficiency
- Hemoglobin electrophoresis (to rule out hemoglobinopathies)
- Coagulation profile (especially in patients on anticoagulants)
Imaging
Upper gastrointestinal series or computed tomography (CT) scans may demonstrate a large hiatal hernia, but they are not useful for detecting the mucosal erosions themselves. However, imaging can be helpful to assess the size and anatomy of the hernia, which is relevant for treatment planning.
Differential Diagnosis
Reflux Esophagitis
Classic reflux esophagitis also presents with mucosal erosions, but they are usually located higher up in the esophagus and are more diffuse. The erosions associated with reflux often have a more pronounced inflammatory infiltrate and may be accompanied by Barrett’s esophagus.
Gastrointestinal Bleeding from Other Sources
- Peptic ulcer disease
- Esophageal varices
- Mallory‑Weiss tear
- Gastric antral ulcers
Inflammatory Bowel Disease (IBD)
IBD can present with mucosal ulcerations in the esophagus, particularly in eosinophilic esophagitis. However, the pattern of lesions and the presence of eosinophilic infiltration differentiate it from Cameron lesions.
Malignancy
Early esophageal carcinoma can occasionally present as superficial erosions or ulcerations. Biopsy is essential to rule out malignancy when lesions are atypical or persist after treatment of GERD.
Management and Treatment
Medical Therapy
Proton Pump Inhibitors (PPIs)
High‑dose PPI therapy is commonly initiated to reduce gastric acid exposure and promote healing of erosions. The typical regimen involves omeprazole 40 mg twice daily or equivalent. Long‑term use may be required, especially in patients with persistent reflux symptoms.
H2 Receptor Antagonists
In patients who cannot tolerate PPIs, H2 blockers such as ranitidine or famotidine may provide partial acid suppression. However, evidence suggests that PPIs are more effective in resolving Cameron lesions.
Iron Supplementation
Oral iron supplements (ferrous sulfate 325 mg daily) are usually prescribed for patients with documented iron deficiency. In severe or refractory anemia, intravenous iron may be considered to accelerate erythropoiesis and reduce the risk of transfusion.
Endoscopic Interventions
Thermal Ablation
In cases where the lesions are large or actively bleeding, endoscopic thermal ablation (argon plasma coagulation or heater probe) can be used to coagulate the mucosa and stop bleeding.
Endoscopic Suturing or Clips
For persistent erosions that do not heal with medical therapy, endoscopic suturing or placement of endoclips along the diaphragmatic margin may provide mechanical reinforcement and reduce mechanical trauma.
Surgical Management
Hiatal Hernia Repair
Patients with large hiatal hernias and persistent Cameron lesions often benefit from surgical repair. Laparoscopic fundoplication with hiatal closure is the most common procedure. The goal is to reduce the hernia size, eliminate the mechanical friction, and restore the gastroesophageal junction’s integrity.
Transhiatal Repair Without Fundoplication
In select patients, a simple transhiatal repair that focuses on reducing the hernia and securing the diaphragmatic hiatus may suffice. However, this approach does not address reflux directly, and the risk of postoperative reflux remains.
Postoperative Care
After hiatal repair, patients are typically started on a proton pump inhibitor and monitored for improvement in anemia and reflux symptoms. Follow‑up EGD may be performed after 3 to 6 months to assess for residual erosions or recurrence.
Prognosis
Outcome with Medical Therapy
When managed appropriately with acid suppression and iron supplementation, the majority of Cameron lesions heal within 6 to 12 weeks. Anemia often resolves over the same period, although in some patients, a lag of several weeks is observed due to the time required for erythropoiesis.
Long‑Term Outcomes
Patients who undergo hiatal hernia repair have a lower recurrence rate of lesions and associated anemia. Long‑term follow‑up (≥ 5 years) shows sustained improvement in symptoms and no significant recurrence of Cameron lesions in most cases.
Complications
- Transient postoperative dysphagia due to edema or mild stricture formation
- Persistent reflux symptoms requiring ongoing PPI therapy
- Anemia requiring repeated iron supplementation
- Surgical complications such as leakage or hernia recurrence
Prognostic Factors
Lesion Size and Number
Large, multiple lesions tend to have a poorer response to medical therapy alone. These patients often require surgical intervention sooner.
Response to PPI Therapy
Patients who fail to show improvement in erosions after a 4‑week PPI trial are at increased risk of anemia relapse. In such cases, early surgical evaluation is recommended.
Refractory Iron‑Deficiency Anemia
Patients who do not respond to oral iron or intravenous iron therapy may have ongoing bleeding from erosions. Prompt evaluation for endoscopic therapy or surgical repair is indicated.
Research and Emerging Therapies
Novel Endoscopic Devices
Recent trials have explored the use of new endoscopic devices, such as bio‑resorbable coatings or silicone patches placed over the diaphragmatic margin, to reduce mechanical stress. Preliminary data suggest these devices may accelerate lesion healing.
Non‑Acidic Proton Pump Inhibitors
Agents that provide acid suppression without altering the gastric pH profile, such as potassium‑competitive acid blockers, are under investigation for their potential to treat erosive lesions more effectively.
Role of Esophageal Motility Studies
High‑resolution esophageal manometry can evaluate motility abnormalities that may predispose patients to erosions. Future research may clarify whether motility disorders contribute significantly to Cameron lesion formation.
Key Takeaways
- Cameron lesions are shallow erosions located along the diaphragmatic margin in patients with large hiatal hernia.
- Mechanical friction, acid reflux, and inflammation are central to their pathogenesis.
- Iron‑deficiency anemia is the most common systemic sign and can be a diagnostic clue.
- EGD with biopsy remains the gold standard for diagnosis.
- Management includes high‑dose PPIs, iron supplementation, and hiatal hernia repair when medical therapy fails.
No comments yet. Be the first to comment!